Maricann Staff, Inc. Good points Publicity to TSX with Record on Horizons Marijuana Existence Sciences Index ETF Canadian Inventory Trade:MARI.CN


TORONTO, Ontario, June 20, 2017 (GLOBE NEWSWIRE) — Maricann Staff Inc. (CSE:MARI) (“Maricann” or the “Corporate”) a low value, greenhouse manufacturer of clinical hashish with marketplace main technological differentiation, is proud to announce that it’s been added to the Horizons Marijuana Existence Sciences Index ETF (TSX:HMMJ). The corporate used to be decided on to enroll in the hashish business’s premier ETF because of its persisted sturdy efficiency within the aggressive Canadian hashish panorama, in addition to having confirmed to satisfy the Index’s required asset and liquidity thresholds.

“Maricann Staff is a growth-oriented corporate in an increasing and thrilling sector,” stated Ben Ward, CEO of Maricann. “We are happy to be incorporated within the Horizon Marijuana Existence Sciences Index ETF (HMMJ), giving us higher publicity to buyers throughout the ETF’s TSX list.”

Debuting at the Toronto Inventory Trade on April fiveth, 2017, HMMJ is the primary exchange-traded fund that can be offering buyers direct publicity to North American-listed shares which are concerned with biopharmaceuticals, clinical production, distribution, bio-products, and different companies ancillary to the marijuana business. Maricann joins the gang of 20 shares tracked by way of the HMMJ ETF.  

“We’re assured that our inclusion will turn out really helpful to each the Corporate and ETF alike,” stated Ward. “Maricann has an absolutely funded enlargement into Germany underway, with the infrastructure for cultivation of hashish in an indoor secured setting already in position. Germany is our gateway into all of Europe, and as hashish legalization continues to brush throughout the continent, we will be able to be properly poised to develop our Eu presence.”

This milestone follows Maricann’s announcement of global enlargement, after securing $42,500,000 in non-dilutive financing to additional extend their operation into Germany. Maricann is slated to supply 40,000 kilograms of hashish according to yr throughout 150,000 sq. toes inside of their new GMP-compliant, clean-room cultivation facility in Dresden. With the potential of 820,000 sq. toes of clean-room cultivation on this facility, Maricann can building up manufacturing and scale features in Europe’s greatest marketplace for clinical hashish.  

For more info in regards to the HMMJ ETF, together with the entire record of securities and the index method, discuss with the HMMJ ETF website online at www.horizonsetfs.com/ETF/HMMJ.

About Maricann Staff Inc. 

Maricann is a vertically built-in manufacturer and distributor of marijuana for clinical functions. The corporate used to be based in 2013 and is based totally in Langton, Ontario, the place it operates a medicinal hashish cultivation, extraction and distribution trade underneath federal licence from the Executive of Canada. Maricann, which has federal licences to domesticate, procedure and distribute hashish, products and services a affected person base with greater than eight,000 general registered sufferers since inception. Maricann is these days endeavor a ramification of its cultivation and beef up amenities in Canada in an absolutely funded 217,000 sq. feet. (20,159 sq. m), to beef up current and long run affected person progress. Maricann GmbH is a 95% owned subsidiary of Maricann Netherlands BV, a 100% wholly owned subsidiary of Maricann Staff Inc.

Maricann Milestones

  • April 2013, Maricann Inc. is based in Langton, Ontario, a well-established agricultural area in southwestern Ontario
  • March 2014, Maricann Inc. obtains its Well being Canada licence to domesticate crops
  • December 2014, Maricann Inc. obtains its Well being Canada licence to promote dried hashish
  • January 2015, first dried hashish sale
  • September 2016, Maricann Inc. earns its Well being Canada licence to promote hashish extracts
  • October 2016, first sale of extracted hashish
  • December 2016, Maricann Inc. raises $22.five million in personal capital
  • January 2017, commences sale of clones
  • February 2017, Maricann Inc. raises $10 million in personal capital
  • April 24, 2017, Maricann Staff, Inc. first day of buying and selling at the CSE
  • April 28, 2017, proclaims Advisory Board of German subsidiary
  • Would possibly four, 2017, Maricann Staff, Inc. secures $42,500,000 non-dilutive financing for additional German enlargement
  • Would possibly 24, 2017, breaks floor on enlargement of cultivation facility in Langton, Ontario
  • June 12, 2017, Maricann Staff, Inc. indexed on HMMJ ETF

For more info about Maricann please discuss with our website online at www.maricann.ca

Ahead Having a look Data
The Canadian Securities Trade has neither authorized nor disapproved the contents of this information free up. This information free up comprises sure forward-looking statements that mirror the present perspectives and/or expectancies of control with admire to efficiency, trade and long run occasions, together with however no longer restricted to precise or implied statements and assumptions in regards to the Corporate’s trade and operations. Ahead-looking statements are in accordance with the then-current expectancies, ideals, assumptions, estimates and forecasts in regards to the trade and the business and markets through which the Corporate operates. Ahead-looking statements aren’t promises of long run efficiency and contain dangers, uncertainties and assumptions which can be tough to are expecting. Accordingly, readers must no longer position undue reliance on forward-looking statements and knowledge, which can be certified of their entirety by way of this cautionary observation. The Corporate does no longer adopt any responsibilities to free up publicly any revisions for updating any voluntary forward-looking statements, with the exception of as required by way of acceptable securities legislation.

Touch Data: 
Investor Members of the family:
Shawn Alexander
VP Investor Members of the family
salexander@maricann.ca
416.258.4784

Media:
Robert Vanisko
North sixth Company
212-334-9753 ext.112
maricann@n6a.com


Company Headquarters:
Maricann Staff Inc. (C.MARI)
845 Harrington Courtroom, Unit three
Burlington Ontario L7N 3P3
Canada

Previous Considerable Enlargement in Hashish Operations and Develop Amenities in North The us Resulting in
Next NanoSphere Well being Sciences Indicators Binding Merger Settlement for 100% Acquisition via Corazon Gold Corp.